Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05645991 · ClinicalTrials.gov registry record · NA

Coconut Sugar Lowers Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults

A NA study of Aging and Blood Pressure, sponsored by Ball State University.

Completed
Registry status
NA
Development phase
22
Enrollment target
1
Study location

NCT05645991 is a NA study of Aging and Blood Pressure that has completed, run by Ball State University. The registered enrollment target is 22 participants, below the 2,195-participant average among 262 other Aging trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05645991, a NA study of Aging and Blood Pressure, has completed, sponsored by Ball State University.

COMPLETED
Registry status
NA
Development phase
22 participants
Enrollment target
1
Study location

Study Summary

The goal of this intervention is to determine the efficacy of coconut sap powder (CSP) to lower arterial stiffness and blood pressure in middle-aged and older adults. Participants will be randomized to the CSP arm or Placebo arm of the study. Primary endpoints include: aortic stiffness assessed by carotid-femoral pulse wave velocity, resting brachial and (non-invasive) carotid blood pressure, and carotid stiffness (e.g. Beta stiffness index, Carotid compliance, Elastic modulus, Distensibility).

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT Coconut Sap Powder (CSP)

Study Locations (1)

Indiana

  • Ball State University - Muncie

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2018-03-08
Est. Completion 2022-01-20
Phase NA

Sponsor

Ball State University

12 total trials

What the Registry Record Tells You About NCT05645991

The ClinicalTrials.gov registry entry for NCT05645991 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,195-participant average among 262 other Aging trials with a reported enrollment target (99% lower). The listed sponsor is Ball State University, which has 12 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Aging appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT05645991 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.

Frequently Asked Questions

What is clinical trial NCT05645991 about?

NCT05645991 is a clinical study titled "Coconut Sugar Lowers Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults". The goal of this intervention is to determine the efficacy of coconut sap powder (CSP) to lower arterial stiffness and blood pressure in middle-aged and older adults. Participants will be randomized to the CSP arm or Placebo arm of the study. Primary endpoints include: aortic stiffness assessed by c...

What is the current status of trial NCT05645991?

This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2018-03-08. Estimated completion is 2022-01-20.

What conditions does trial NCT05645991 study?

This clinical trial studies the following conditions: Aging, Blood Pressure, Arterial Stiffness.

What interventions are being tested in trial NCT05645991?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Coconut Sap Powder (CSP) (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT05645991?

This trial is sponsored by Ball State University, which has 12 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05645991 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aging

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.